152 related articles for article (PubMed ID: 24821909)
21. Biochemical and structural analysis of the interaction between β-amyloid and fibrinogen.
Zamolodchikov D; Berk-Rauch HE; Oren DA; Stor DS; Singh PK; Kawasaki M; Aso K; Strickland S; Ahn HJ
Blood; 2016 Aug; 128(8):1144-51. PubMed ID: 27389717
[TBL] [Abstract][Full Text] [Related]
22. The Alzheimer's disease peptide β-amyloid promotes thrombin generation through activation of coagulation factor XII.
Zamolodchikov D; Renné T; Strickland S
J Thromb Haemost; 2016 May; 14(5):995-1007. PubMed ID: 26613657
[TBL] [Abstract][Full Text] [Related]
23. Venular degeneration leads to vascular dysfunction in a transgenic model of Alzheimer's disease.
Lai AY; Dorr A; Thomason LA; Koletar MM; Sled JG; Stefanovic B; McLaurin J
Brain; 2015 Apr; 138(Pt 4):1046-58. PubMed ID: 25688079
[TBL] [Abstract][Full Text] [Related]
24. Fibrinogen Activates BMP Signaling in Oligodendrocyte Progenitor Cells and Inhibits Remyelination after Vascular Damage.
Petersen MA; Ryu JK; Chang KJ; Etxeberria A; Bardehle S; Mendiola AS; Kamau-Devers W; Fancy SPJ; Thor A; Bushong EA; Baeza-Raja B; Syme CA; Wu MD; Rios Coronado PE; Meyer-Franke A; Yahn S; Pous L; Lee JK; Schachtrup C; Lassmann H; Huang EJ; Han MH; Absinta M; Reich DS; Ellisman MH; Rowitch DH; Chan JR; Akassoglou K
Neuron; 2017 Dec; 96(5):1003-1012.e7. PubMed ID: 29103804
[TBL] [Abstract][Full Text] [Related]
25. Fibrinogen Induces Microglia-Mediated Spine Elimination and Cognitive Impairment in an Alzheimer's Disease Model.
Merlini M; Rafalski VA; Rios Coronado PE; Gill TM; Ellisman M; Muthukumar G; Subramanian KS; Ryu JK; Syme CA; Davalos D; Seeley WW; Mucke L; Nelson RB; Akassoglou K
Neuron; 2019 Mar; 101(6):1099-1108.e6. PubMed ID: 30737131
[TBL] [Abstract][Full Text] [Related]
26. Fibrinogen in neurological diseases: mechanisms, imaging and therapeutics.
Petersen MA; Ryu JK; Akassoglou K
Nat Rev Neurosci; 2018 May; 19(5):283-301. PubMed ID: 29618808
[TBL] [Abstract][Full Text] [Related]
27. Pericyte degeneration causes white matter dysfunction in the mouse central nervous system.
Montagne A; Nikolakopoulou AM; Zhao Z; Sagare AP; Si G; Lazic D; Barnes SR; Daianu M; Ramanathan A; Go A; Lawson EJ; Wang Y; Mack WJ; Thompson PM; Schneider JA; Varkey J; Langen R; Mullins E; Jacobs RE; Zlokovic BV
Nat Med; 2018 Mar; 24(3):326-337. PubMed ID: 29400711
[TBL] [Abstract][Full Text] [Related]
28. The Effect of Reduced Fibrinogen on Cerebrovascular Permeability during Traumatic Brain Injury in Fibrinogen Gene Heterozygous Knockout Mice.
Sulimai N; Brown J; Lominadze D
Biomolecules; 2024 Mar; 14(4):. PubMed ID: 38672403
[TBL] [Abstract][Full Text] [Related]
29. Lecanemab blocks the effects of the Aβ/fibrinogen complex on blood clots and synapse toxicity in organotypic culture.
Singh PK; Simões-Pires EN; Chen ZL; Torrente D; Calvano M; Sharma A; Strickland S; Norris EH
Proc Natl Acad Sci U S A; 2024 Apr; 121(17):e2314450121. PubMed ID: 38621133
[TBL] [Abstract][Full Text] [Related]
30. Screening Techniques for Drug Discovery in Alzheimer's Disease.
Maniam S; Maniam S
ACS Omega; 2024 Feb; 9(6):6059-6073. PubMed ID: 38371787
[TBL] [Abstract][Full Text] [Related]
31. Lecanemab Blocks the Effects of the Aβ/Fibrinogen Complex on Blood Clots and Synapse Toxicity in Organotypic Culture.
Singh PK; Pires ENS; Chen ZL; Torrente D; Calvano M; Sharma A; Strickland S; Norris EH
bioRxiv; 2024 Jan; ():. PubMed ID: 38293058
[TBL] [Abstract][Full Text] [Related]
32. Cellular mechanisms of fibrin (ogen): insight from neurodegenerative diseases.
Wen T; Zhang Z
Front Neurosci; 2023; 17():1197094. PubMed ID: 37529232
[TBL] [Abstract][Full Text] [Related]
33. Fiberoptic hemodynamic spectroscopy reveals abnormal cerebrovascular reactivity in a freely moving mouse model of Alzheimer's disease.
Gareau DS; RochaKim N; Choudhury A; Bamkole M; Snuderl M; Zou J; Yaroslavsky A; Jacques SL; Strickland S; Krueger JG; Ahn HJ
Front Mol Neurosci; 2023; 16():1163447. PubMed ID: 37465366
[TBL] [Abstract][Full Text] [Related]
34. Vascular Dysfunction in Alzheimer's Disease: Alterations in the Plasma Contact and Fibrinolytic Systems.
Badimon A; Torrente D; Norris EH
Int J Mol Sci; 2023 Apr; 24(8):. PubMed ID: 37108211
[TBL] [Abstract][Full Text] [Related]
35. Striatal fibrinogen extravasation and vascular degeneration correlate with motor dysfunction in an aging mouse model of Alzheimer's disease.
Berk-Rauch HE; Choudhury A; Richards AT; Singh PK; Chen ZL; Norris EH; Strickland S; Ahn HJ
Front Aging Neurosci; 2023; 15():1064178. PubMed ID: 36967821
[No Abstract] [Full Text] [Related]
36. Blood Coagulation and Beyond: Position Paper from the Fourth Maastricht Consensus Conference on Thrombosis.
Akbulut AC; Arisz RA; Baaten CCFMJ; Baidildinova G; Barakzie A; Bauersachs R; Ten Berg J; van den Broek WWA; de Boer HC; Bonifay A; Bröker V; Buka RJ; Ten Cate H; Ten Cate-Hoek AJ; Cointe S; De Luca C; De Simone I; Diaz RV; Dignat-George F; Freson K; Gazzaniga G; van Gorp ECM; Habibi A; Henskens YMC; Iding AFJ; Khan A; Koenderink GH; Konkoth A; Lacroix R; Lahiri T; Lam W; Lamerton RE; Lorusso R; Luo Q; Maas C; McCarty OJT; van der Meijden PEJ; Meijers JCM; Mohapatra AK; Nevo N; Robles AP; Poncelet P; Reinhardt C; Ruf W; Saraswat R; Schönichen C; Schutgens R; Simioni P; Spada S; Spronk HMH; Tazhibayeva K; Thachil J; Diaz RV; Vallier L; Veninga A; Verhamme P; Visser C; Watson SP; Wenzel P; Willems RAL; Willers A; Zhang P; Zifkos K; van Zonneveld AJ
Thromb Haemost; 2023 Aug; 123(8):808-839. PubMed ID: 36913975
[TBL] [Abstract][Full Text] [Related]
37. The predictive value of fibrinogen in the occurrence of mild cognitive impairment events in patients with diabetic peripheral neuropathy.
Zhuang Y; Huang H; Fu Z; Zhang J; Cai Q
BMC Endocr Disord; 2022 Nov; 22(1):267. PubMed ID: 36324107
[TBL] [Abstract][Full Text] [Related]
38. Defibrinogenation Ameliorates Retinal Microgliosis and Inflammation in A CX3CR1-Independent Manner.
Sarker B; Cardona SM; Church KA; Vanegas D; Velazquez P; Rorex C; Rodriguez D; Mendiola AS; Kern TS; Domingo ND; Stephens R; Muzzio IA; Cardona AE
ASN Neuro; 2022; 14():17590914221131446. PubMed ID: 36221892
[TBL] [Abstract][Full Text] [Related]
39. Direct Oral Anticoagulants (DOACs) for Therapeutic Targeting of Thrombin, a Key Mediator of Cerebrovascular and Neuronal Dysfunction in Alzheimer's Disease.
Grossmann K
Biomedicines; 2022 Aug; 10(8):. PubMed ID: 36009437
[TBL] [Abstract][Full Text] [Related]
40. A Leaky Blood-Brain Barrier to Fibrinogen Contributes to Oxidative Damage in Alzheimer's Disease.
McLarnon JG
Antioxidants (Basel); 2021 Dec; 11(1):. PubMed ID: 35052606
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
